Prospective high-throughput genome profiling of advanced cancers: results of the PERMED-01 clinical trial
2021 · Genome Medicine · 53 citations
https://doi.org/10.1186/s13073-021-00897-9
P
Patrick Sfumato
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
41
Papers
388
Citations
10
h-index
12
i10-index
Patrick Sfumato is an academic researcher from Institut Paoli-Calmettes. The author has contributed to research in topics: Prostate Cancer Treatment and Research & Statistical Methods in Clinical Trials & Cancer Genomics and Diagnostics. The author has an h-index of 10, co-authored 35 publications.
ORCID: 0000-0003-3740-5194Papers by this author
worksImmunohistochemical subtypes predict survival in metastatic breast cancer receiving high-dose chemotherapy with autologous haematopoietic stem cell transplantation
2016 · European Journal of Cancer · 5 citations
https://doi.org/10.1016/j.ejca.2016.01.005
A stratified adaptive two-stage design with co-primary endpoints for phase II clinical oncology trials
2022 · BMC Medical Research Methodology · 2 citations
https://doi.org/10.1186/s12874-022-01748-w
Additional file 3 of Prospective high-throughput genome profiling of advanced cancers: results of the PERMED-01 clinical trial
2021 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.14615302
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat